Thiogenesis Therapeutics, Corp.
TTIPF
$0.58
$0.00-0.27%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.73M | -1.37M | -983.00K | -805.10K | -481.60K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 216.10K | 155.90K | 89.50K | 118.20K | 27.10K |
| Change in Net Operating Assets | -27.40K | 369.90K | 315.30K | 302.20K | -157.60K |
| Cash from Operations | -1.54M | -847.10K | -578.20K | -384.70K | -612.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.81M | -- | -- | 253.90K | 7.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.77M | -- | -- | 181.40K | 5.10K |
| Foreign Exchange rate Adjustments | -21.00K | 800.00 | -2.40K | -10.30K | 3.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.20M | -846.40K | -580.70K | -213.70K | -603.60K |